There are many, many tech startups tackling the problem of diabetes. You only have to look at the TechCrunch tag to find some of the latest, and even the Apple Watch is getting in on the act.

But literally ‘reversing’ Type 2 diabetes remains a tough nut to crack. That’s not prevented UK startup OurPath from convincing investors it’s on the right… path.

This digital lifestyle change programme which aims to help patients with this disease, has now raised a $3m round of funding.


Continue Reading OurPath raises $3M in round led by Connect Ventures to ‘reverse’ Type 2 Diabetes